Abstract
Post-coronavirus illness 2019 (post-COVID-19) syndrome has been identified in a number of patients who initially experienced symptoms during the initial stages of the 2019 coronavirus disease pandemic. Since SARS-CoV-2 is a respiratory coronavirus that induces COVID-19, lung damage is a common complication; however, many other cells & organs are typically harmed as well, resulting in a wide range of symptoms. Patients with mild to severe COVID-19 experience these long-lasting symptoms, however there is little published research on the possible pathophysiological reasons behind this disease. This comprehensive study aims to sum up & assess the biological evidence surrounding post-COVID-19 syndrome. The research reviewed up to August 30, 2021 was included in an integrated review using the methods developed by Whittemore & Knafl.
Publisher
International Consortium of Academic Professionals for Scientific Research
Reference63 articles.
1. Amenta, E. M., Spallone, A., Rodriguez-Barradas, M. C., El Sahly, H. M., Atmar, R. L., Kulkarni, P. A. (2020). Postacute COVID-19: An overview and approach to classification. Open Forum Infectious Diseases, 7, ofaa509. 10.1093/ofid/ofaa509
2. Astuti, I., Ysrafil (2020). Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response. Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 14, 407–412. 10.1016/j.dsx.2020.04.020
3. Bolourani, S., Brenner, M., Wang, P. (2021). The interplay of DAMPs, TLR4, and proinflammatory cytokines in pulmonary fibrosis. Journal of Molecular Medicine, 99, 1373–1384. 10.1007/s00109-021- 02113-y
4. Carfi, A., Bernabei, R., Landi, F. (2020). Persistent symptoms in patients after acute COVID-19. JAMA, 324, 603–605. 10.1001/jama. 2020.12603
5. Centers for Disease Control and Prevention. (2021). Post-COVID conditions: Information for healthcare providers. https://www.cdc. gov/coronavirus/2019-ncov/hcp/clinical-care/post-covidconditions.html